Fig. 2.
Effect of IL-2 treatment on splenic regulator T (TREG) cells in control and systemic lupus erythematosus (SLE) mice. A: percentages of CD4+Foxp3+ TREG cells at the conclusion of the study. *P < 0.05 vs. IL-2-treated control and IL-2-treated SLE groups. B: percentages of CD3+CD4+ T lymphocytes at the conclusion of the study. P values were generated using one-way ANOVA followed by a Tukey’s post test for multiple comparisons.